KIMBERLY CLARK CORP — Form 8-K
Filed November 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
On November 2, 2026, Kimberly-Clark completed its acquisition of Kenvue (spinoff of J&J's consumer health business). Q3 2026 net sales were $4.1B (down 0.4% reported; organic sales down 1.3% due to ~270bps China social media disruption headwind and North America inventory movements). Adjusted operating profit declined 0.9% YoY to $677M; adjusted EPS from continuing operations rose 17.2% to $1.70 (aided by lower interest expense and tax rate), but adjusted EPS attributable to KMB fell 6.6% to $1.70 due to discontinued operations. Company reaffirmed 2026 guidance: organic sales ~100bps below category growth (~1.7%); adjusted operating profit growth mid-single digits; adjusted EPS from continuing operations growth high single digits on constant-currency basis.
Why this rating
Kenvue acquisition materially transforms KMB's portfolio and size (estimated ~$13B+ incremental revenue). Significant integration execution risk, substantial debt incurrence ($1.3B+ proceeds noted), and near-term earnings headwinds from China disruption and pricing pressure. However, core business remains stable; dividend raised. Meaningful deal relative to $42.8B market cap, but integration success uncertain.
Price action (we called it neutral)
before filing · preread $109.53 ▲ 0.82% | at our read · unknown $108.64 | +10 min · unknown $110.06 ▲ 1.30% | +30 min · unknown $110.57 ▲ 1.78% | +1 hr · unknown $111.77 ▲ 2.88% | +4 hrs · unknown $110.21 ▲ 1.45% |
The stock had already moved -0.81% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.